<DOC>
	<DOCNO>NCT01879657</DOCNO>
	<brief_summary>To evaluate concordance discordance result 68Ga-DOTATATE PET-CT scan OctreoScan ® consider standard care diagnostic test neuroendocrine cancer image modality like CT scan/MRI gold standard .</brief_summary>
	<brief_title>68-Ga-DOTATATE PET-CT Scan Diagnosis Staging Neuroendocrine Tumors</brief_title>
	<detailed_description>The number lesion could identify clearly single focus determine patient . The anatomic area image 68Ga-DOTATATE PET 111In-penteoctreotide Scintigraphy ensure relevant comparison lesion detection . Because confluence inability clearly delineate single liver lesion case , liver metastasis classify 1 organ metastasis , independent number liver metastases present . Lymph nod small 1 cm CT MRI show marked avidity 68Ga- DOTATATE 111In-penteoctreotide label positive disease . The presence lesion confirm cross-sectional imaging patient CT MRI .</detailed_description>
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Carcinoid Tumor</mesh_term>
	<mesh_term>Carcinoma , Neuroendocrine</mesh_term>
	<criteria>Patients either gender , age least 18 year . Karnofsky status equal great 60 . Life expectancy least 12 week . Histologically and/or clinically confirm and/or suspicious NET . Somatostatinanalogue scintigraphies scan result ( positive negative ) within last 4 week . Recent Blood test result 23 week follow : ( WBC : equal/higher 2*109/L ; Haemoglobin : equal/higher 8.0g/Dl ; Platelets : equal/higher 50x109/L ; ALT , AST , AP : equal/lower 5 time ULN ; Bilirubin : equal/lower 3 time ULN ; Serum creatinine : within normal range &lt; 120μmol/L patient age 60 year old . Negative pregnancy test woman capable childbearing . Known hypersensitivity DOTA , 68Gallium , Octreotate excipients 68GaDOTATATE . Therapeutic use somatostatin analogue , include Sandostatin® LAR ( within 28 day ) Sandostatin® ( within 2 day ) prior study imaging . If patient Sandostatin® LAR washout phase 28 day require injection study drug . Pregnant breastfeed woman . Current somatic psychiatric disease/condition may interfere objective assessment study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>